Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

NCT01617824 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Chronic Renal Failure

Interventions

DRUG: Linagliptin
DRUG: Placebo

Sponsor

University of Padova